No more guessing who looks 18: Sweden's biggest snus seller checks ID on every customer, after test purchases found most young-looking buyers were never asked.

market

A month after Philip Morris International hit Rep. Marie Gluesenkamp Perez with a cease-and-desist over a Zyn-branded campaign tin, she's selling a redesigned version that keeps the shape but drops the brand's name.

market

On 1 October 2026, Swedish Match sold its emptied snus factory in Roma, Gotland — production ended in March and moved to Kungälv — to Free Factory AB, part of Ara Abrahamian's Habit Factory group. The former Olympic wrestler plans to restart snus production on the site.

regulation

From October 1, the maker of ZYN requires ID from every buyer in its own Swedish stores, no matter how old they look. The company is also calling for a national ban on buying nicotine products for minors.

regulation

Effective October 1, Swedish Match requires age verification for all nicotine purchases in its own shops, after a mystery-shopper survey found only 46% of Swedish stores check ID.

trend

Philip Morris International hiked its annual dividend to $6.40 per share, an 8.8% increase driven largely by its nicotine pouch business. The company has now raised payouts 248% since going public.

market

Sweden has rejected the EU's proposed tax on nicotine pouches, blocking Brussels' attempt to treat them like cigarettes under excise rules.

market

Nicotine pouch use among Swedish teens tripled in one year, jumping from 7% to 19% between 2019 and 2020. The products aren't covered by tobacco law — meaning no age restrictions.

regulation

On 21 August 2026 the FDA issued Marketing Granted Orders for 11 ZYN Ultra nicotine pouches from Swedish Match USA — ten 9mg flavours and a new 11mg Smooth. The authorizations push the total of FDA-authorized nicotine pouch products to 43, with 23 cleared through the agency’s nicotine pouch pilot program. The American Lung Association attacked the move, citing youth appeal.

regulation

The FDA issued Modified Risk Tobacco Product orders for 20 ZYN nicotine pouch products on 30 June 2026 — the first time any nicotine pouch has been cleared to advertise reduced disease risk versus cigarettes. The authorised claim covers mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis. Public health experts say the labelling could normalise nicotine for new users — and point to 460,000 youth pouch users as evidence the category is already reaching kids.

science

A University of Gothenburg randomized crossover study found that dental plaque acidogenicity — a key cavity-risk marker — decreased over six weeks when snus users switched to ZYN nicotine pouches, even though cavity-causing bacteria levels went up.

regulation

The FDA has authorized 30 nicotine pouch products in 2026 — including 20 ZYN pouches with reduced-risk claims and four new flavored on! pouches. Public health groups, pediatricians and parents responded by suing the agency, arguing its enforcement policy lets products reach the market without legally required scientific review. The American Heart Association says the program was "never adequately explained to the public."

market

Philip Morris International has opened a $1.2 billion ZYN manufacturing campus in Aurora, Colorado — its largest US facility and the biggest bet yet on nicotine pouch production. The 780,000-square-foot plant employs 500 people and began commercial output in July 2026.

regulation

In June 2026 the FDA let 20 ZYN nicotine pouch products carry a modified-risk claim — a first for the category. Here's the exact wording, the full product list, and why it matters for every pouch brand.